Valdez RJA, Hernández OHG, González SN, Cravioto QP

Language: Spanish
References: 16
Page: 62-67
PDF size: 360.85 Kb.

ABSTRACT

Ventilator-associated pneumonia (VAP) is the most common infectious complication in all intensive care units worldwide, causing a significant increase in social and economic costs. The application of resources for the prevention of VAP is an unfelt need; therefore, it is necessary to evaluate the costs of this type of infections. The objective of this study is to know the cost of VAP in a pediatric intensive care unit. We analyzed 92 pneumonia events by calculating the fixed and variable direct costs of care; the cost per event was $ 6,174.89, and the total cost was $ 670,608.03. The total cost of pneumonias represents 4.4% of the institute’s total resources, as reported by the 2015 Quality, Work and Safety Program. It is necessary to disclose the savings that would mean the reduction of these events according to the expenditure made in the care of VAP in the institution, in order to allocate resources to strategies to prevent this problem.

REFERENCES

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171 (4): 388-416.

2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002; 165 (7): 867-903.

3. Guía de Práctica Clínica. Prevención, diagnóstico y tratamiento de la neumonía asociada a ventilación mecánica. México: Secretaría de Salud; 2013.

4. Rello J, Ollendorf D, Oster G, Vera-Llonch M, Bellm L, Redman R et al. VAP outcomes scientific advisory group: epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002; 122: 2115-2121.

5. Información del Sistema de Vigilancia del Comité de Infecciones Asociadas a la Atención de la Salud. Datos no publicados.

6. Hernández OH, Castañeda NJ, Lucas RM et al. Prevención de neumonía asociada a ventilación con paquete de verificación en la unidad de cuidados intensivos. Estudio piloto. Acta Ped Mex. 2016; 37 (6): 322-327.

7. Pinto D. Estudios de análisis económico. En: Ruiz MA, Morillo ZLE. Epidemiología clínica. Investigación clínica aplicada. Bogotá, Colombia: Editorial Médica Panamericana; 2004. p. 309-325.

8. Haddix AC, Shaffer PA. Prevention effectiveness: a guide to decision analysis and economic evaluation. New York, USA: Oxford University Press; 2013.

9. SSA. Catálogo de beneficios médicos (CABEME). 2002. p. 35-48.

10. CDC. Pneumonia (ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU]) event. Disponible en: https://www.cdc.gov/nhsn/pdfs/pscmanual/6pscvapcurrent.pdf. [Consultada en enero de 2015].

11. SSA. Norma oficial mexicana, NOM 045 SSA2 2005, Para la prevención y control de infecciones nosocomiales. [Consultada en enero de 2014]. Disponible en: http://dof.gob.mx/nota_detalle.php?codigo=5120943&fecha=20/11/2009.

12. Dudeck MA, Weiner LM, Allen-Bridson K et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. Am J Infect Control. 2013; 41: 1148-1166.

13. Salvatierra-González MR. Costo de la infección nosocomial en nueve países de América Latina. Washington DC; OPS, 2003; p. 63-84.

14. Instituto Nacional de Pediatría. Programa de trabajo 2015. [Consultado en diciembre de 2015]. Disponible en: http://www.pediatria.gob.mx/progra_2015.pdf.

15. INEGI. Ingresos y gastos en los hogares. [Consultado en diciembre de 2015]. Disponible en: http://www.inegi.org.mx/saladeprensa/boletines/2015/especiales/especiales2015_07_3.pdf.

16. Bird D, Zambuto A, O’Donnell Ch, Silva J, Korn C, Burke R et al. Adherence to ventilator-associated pneumonia bundle and incidence of ventilator-associated pneumonia in the surgical Intensive Care Unit. Arch Surg. 2010; 145 (5): 465-470.